2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
FDA Comment Number : | EC3317 | |||||||||||||||||||||||
Submitter : | Mr. Pedro Najera | Date & Time: | 12/15/2006 08:12:41 | |||||||||||||||||||||
Organization : | Mr. Pedro Najera | |||||||||||||||||||||||
Category : | Individual Consumer | |||||||||||||||||||||||
Issue Areas/Comments | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
GENERAL | ||||||||||||||||||||||||
This is to request that ethical cell lines be used in vaccine production. | ||||||||||||||||||||||||